to study the effect of treatment on plasma lipid and lipoprotein concentration and on postheparin-lipolytic activity ( phla ) in plasma , 26 noninsulin-dependent diabetics were investigated who were treated with maximally effective doses of glibenclamide .
C0011860
noninsulin-dependent
C0017628
glibenclamide